Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Focused Fund median (28 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Jan 2022 – 20 Aug 2026, limited by Sundaram Focused Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Sundaram Focused Fund | Nifty 500 |
|---|---|---|
| 03 Jan 2022 | ₹100.00 | ₹100.00 |
| 24 May 2022 | ₹87.52 | ₹90.42 |
| 12 Oct 2022 | ₹96.37 | ₹97.54 |
| 02 Mar 2023 | ₹95.76 | ₹95.94 |
| 20 Jul 2023 | ₹112.48 | ₹112.09 |
| 08 Dec 2023 | ₹120.51 | ₹123.01 |
| 27 Apr 2024 | ₹133.97 | ₹137.06 |
| 15 Sep 2024 | ₹155.46 | ₹157.37 |
| 03 Feb 2025 | ₹141.63 | ₹140.76 |
| 24 Jun 2025 | ₹147.80 | ₹152.01 |
| 11 Nov 2025 | ₹151.02 | ₹155.76 |
| 01 Apr 2026 | ₹134.80 | ₹137.69 |
| 20 Aug 2026 | ₹159.13 | ₹154.64 |
| Metric | Sundaram · Direct NAV ₹190.09 Very High risk ★★☆☆☆ | Category median Focused Fund · 28 funds |
|---|---|---|
| +6.18% | +5.84% | |
| +12.64% | +15.09% | |
| — | +13.35% | |
| — | +13.62% | |
| +10.56% | +15.49% | |
| +11.93% | — | |
| +14.36% | +16.73% | |
| — | +16.52% | |
| — | +16.05% | |
| Risk | ||
| 13.33% | 14.55% | |
| 0.46 | 0.57 | |
| 0.64 | 0.79 | |
| -20.08% | -34.05% | |
| Nifty 500 | — | |
| +1.64% | +3.16% | |
| 0.80 | 0.94 | |
| 91.0% | 104.9% | |
| 79.5% | 89.6% | |
| 1.30% | 1.06% | |
| ₹975.13Cr | ₹2,441Cr | |
| 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹300 | — | |
| 54% | 32% | |
| Sudhir Kedia | — | |
| 03 Jan 2022 | — | |
| 28 | — | |
| 53.6% | — | |
| 6.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.